Peter P. Luk
Camperdown, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Emicizumab and Recombinant FVIIa for Safe Surgical Removal of a Massive Pseudotumor in Severe Hemophilia A with Inhibitor.
Journal: Seminars in thrombosis and hemostasis
Published: August 04, 2026
International Consensus Guidelines for Diagnostic Criteria and Checklist for Future Studies for Minimally Invasive Carcinoma ex Pleomorphic Adenoma: An HN CLEAR Initiative.
Journal: Head and neck pathology
Published: November 19, 2025
Prognostic and predictive biomarkers in head and neck cancer: something old, something new, something borrowed, something blue and a sixpence in your shoe.
Journal: Pathology
Published: October 30, 2023
Left cheek sclerosing rhabdomyosarcoma and development of isolated free flap donor site metastasis.
Journal: BMJ case reports
Published: April 08, 2022
Catheter entrapment in the Chiari network during catheter ablation.
Journal: HeartRhythm case reports
Published: December 28, 2020
PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma.
Journal: Cancer reports (Hoboken, N.J.)
Published: September 02, 2020
NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
Journal: Pathology
Published: August 01, 2020
A critical analysis of the 8th edition TNM staging for head and neck cutaneous squamous cell carcinoma with lymph node metastases and comparison to N1S3 stage and ITEM risk score: A multicenter study.
Journal: Journal of surgical oncology
Published: May 29, 2020
Number of nodal metastases and the American Joint Committee on cancer staging of head and neck cutaneous squamous cell carcinoma: A multicenter study.
Journal: Oral oncology
Published: March 25, 2020
Last Updated: 09/26/2026